Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03283878 · ClinicalTrials.gov registry record · Phase 4
Antibiotic Prophylaxis in Patients Undergoing Elective Total Knee Arthroplasty- Multi-center Trial
A Phase 4 study, sponsored by Duke University.
- Completed
- Registry status
- Phase 4
- Development phase
- 1,770
- Enrollment target
NCT03283878: Completed Phase 4 study, sponsored by Duke University.
NCT03283878 is a Phase 4 study that has completed, run by Duke University. The registered enrollment target is 1,770 participants, above the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (242% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03283878, a Phase 4 study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 1,770 participants
- Enrollment target
Study Summary
The Antibiotic Prophylaxis in Patients Undergoing Elective Total Knee Arthroplasty (TKA): Multi-Center Trial is a study that will compare the effectiveness of various perioperative strategies for antibiotic delivery as prophylaxis for periprosthetic joint infections (PJI) and surgical site infection in elective primary TKA. The investigators hypothesize that a single dose of prophylactic antibiotic administered within 60 minutes before the incision is not an effective way to prevent PJI in elective primary total knee arthroplasty (TKA). The investigators also hypothesize that the prolonged delivery (24 hours) of antibiotic prophylaxis after surgery does not further reduce the incidence of PJI in elective primary TKA. Duke University is the only site recruiting both primary total knee arthroplasty and unilateral knee arthroplasty.
Interventions
- DRUG Cefazolin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,770 participants |
| Start Date | 2017-10-24 |
| Est. Completion | 2025-08-22 |
| Phase | Phase 4 |
What the finished NCT03283878 record still lists
NCT03283878 is an interventional study that assigns participants to a tested intervention. Its 1,770 participants enrollment target places it among the larger protocols in the corpus, above the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (242% higher).
The record links to 0 conditions, and to 1 intervention - of which Cefazolin is the first listed.
NCT03283878 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03283878 about?
NCT03283878 is a clinical study titled "Antibiotic Prophylaxis in Patients Undergoing Elective Total Knee Arthroplasty- Multi-center Trial". The Antibiotic Prophylaxis in Patients Undergoing Elective Total Knee Arthroplasty (TKA): Multi-Center Trial is a study that will compare the effectiveness of various perioperative strategies for antibiotic delivery as prophylaxis for periprosthetic joint infections (PJI) and surgical site infection...
What is the current status of trial NCT03283878?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 1,770 participants. The study started on 2017-10-24. Estimated completion is 2025-08-22.
What interventions are being tested in trial NCT03283878?
The interventions under investigation include: Cefazolin (DRUG).
Who is sponsoring clinical trial NCT03283878?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03283878's enrollment target sits among peer trials
1,770 45th of 2000 higher than 1,956 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06239688 · 1,764 participants · NA
Evaluating a National Person-Centered Training Program to Strengthen the Dementia Care Workforce
- NCT03067181 · 1,780 participants · Phase 3
Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors
- NCT06526650 · 1,780 participants · NA
'Ai Pono Cooking Demonstrations
- NCT05770570 · 1,785 participants · Phase 2
Taxi ROADmAP (Realizing Optimization Around Diet And Physical Activity)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI